Skip to main content
Clinical Trials/NCT00739440
NCT00739440CompletedPhase 4

Randomized Controlled Trial to Evaluate Efficiency and Safety of the Polyvalent Antiscorpion Serum of Birmex Versus Other Commercial Serum

Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.0 sites120 target enrollmentStarted: August 1, 2008Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
120
Primary Endpoint
Resolution of signs and symptoms of scorpion envenomation

Study Overview

Brief Summary

The purpose of this study is to compare the efficiency and safety of the treatment against sting scorpion, using two serums, one elaborated by Birmex versus other commercial serum

Detailed Description

We consider relevant conduct this study because the poisoning scorpion bite represents a public health problem.

This is a randomized clinical trial, which included 120 subjects of both sexes aged 15 and 60 years old and residents of the state of Guanajuato, divided into 2 groups: 60 patients received antiscorpion serum of Birmex and 60 patients receive other commercial serum.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
15 Years to 60 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Sting scorpion
  • Informed consent
  • Age 15-60
  • Either sex
  • Resident in study area

Exclusion Criteria

  • Previous treatment with gammaglobulin
  • Blood transfusion at any stage of life
  • Sensitivity or intolerance to serums antiscorpion or horse products
  • Pregnancy
  • Some immunodeficiency

Outcomes

Primary Outcomes

Resolution of signs and symptoms of scorpion envenomation

Time Frame: after treatment (expected average of 12 hrs)

Secondary Outcomes

  • Evaluate the adverse events in every treated child(inmediately after treatment and until 5 days later)

Investigators

Sponsor
Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.
Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials